Should the Start of Immunosuppressive Treatment for COVID-19 Rely upon the Degree of Inflammation or the Time from Onset?

Should the Start of Immunosuppressive Treatment for COVID-19 Rely upon the Degree of Inflammation or the Time from Onset?

<i>Background and Objectives:</i> A COVID-19 model with a viral first-week phase and an inflammatory second phase has been proposed. It has been suggested that immunosuppressive treatment in the first week is harmful. This study aimed to analyze the potential damage of corticosteroids (C...

Full description

Saved in:
Bibliographic Details
Main Authors: José María Mora-Luján, Abelardo Montero, Francesc Formiga, Manuel Rubio-Rivas
Format: Article
Language:English
Published: MDPI AG 2025-01-01
Series:Medicina
Subjects:
COVID-19
treatment
corticosteroids
prognosis
risk factors
mortality
Online Access:https://www.mdpi.com/1648-9144/61/2/233
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items